COVID-19: Jubilant Life Sciences gets DCGI nod for generic version of antiviral drug remdesivir

Jubilant's remdesivir will be marketed under the brand name 'JUBI-R' in India and will be made available in 100 mg vials (injectable), it added.

from Lifestyle News:Entertainment News,Bollywood Latest News,Box Office Collection Report,Movie Reviews
Read The Rest:financialexpress...